Global Stomach Tube Market Size By Type (Nasojejunal Feeding Tube, Gastrostomy or Gastric Feeding Tube), By Application (Children, Dementia), By Region, And Segment Forecasts, 2023 to 2032

The Global Stomach Tube Market was valued at USD X.X billion in 2023 and is projected to surpass USD X.X billion by 2031, growing at a CAGR of X.X% during the forecast period of 2023-2031. The increasing prevalence of gastrointestinal disorders, growing demand for enteral feeding among the elderly population, and advancements in tube manufacturing technology are key drivers of the market. Stomach tubes are critical medical devices used for feeding, decompression, and drainage in patients with swallowing difficulties, surgical conditions, or chronic diseases.

The market is witnessing a rise in demand due to an aging population, increased incidence of dysphagia (swallowing difficulties), and higher hospital admissions for long-term care. In addition, technological advancements, such as the development of bio-compatible and anti-clogging tubes, are boosting the adoption of stomach tubes in hospitals and home care settings.

Drivers

1. Rising Geriatric Population & Increased Demand for Enteral Feeding

With an aging global population, the demand for enteral feeding is increasing. Stomach tubes are widely used for patients with dysphagia, neurological disorders, and post-surgical recovery, leading to market growth.

2. Growing Prevalence of Gastrointestinal Disorders

The rise in gastrointestinal disorders such as gastroesophageal reflux disease (GERD), esophageal cancer, and gastroparesis has increased the demand for stomach tubes. Patients suffering from such conditions often require enteral nutrition, further propelling market expansion.

3. Technological Advancements in Tube Design

Innovation in materials, such as silicone-based and biodegradable tubes, is improving patient comfort and reducing complications such as tube clogging or infections. The adoption of antimicrobial-coated stomach tubes is also reducing hospital-acquired infections.

Restraints

1. Risks and Complications Associated with Stomach Tubes

Despite their benefits, stomach tubes carry risks such as infections, blockages, leakage, and discomfort for patients. These factors can limit widespread adoption, particularly in home care settings.

2. High Cost of Advanced Stomach Tubes

The cost of innovative stomach tubes with anti-clogging features and antimicrobial coatings is higher than traditional tubes. This can limit their use in price-sensitive markets, particularly in low-income regions.

3. Regulatory Challenges

Strict regulations governing the manufacturing and distribution of medical devices, including stomach tubes, can slow down product approvals and market entry, thereby limiting growth opportunities.

Opportunity

1. Expansion of Home Healthcare Services

The increasing shift towards home-based healthcare services, particularly for elderly and chronically ill patients, presents a significant opportunity for market growth. Home enteral nutrition is becoming more common, creating demand for easy-to-use stomach tubes.

2. Emerging Markets in Asia-Pacific and Latin America

Developing countries are witnessing an increase in healthcare infrastructure, disposable income, and awareness about enteral feeding solutions. The expansion of hospitals and home care services in these regions is expected to drive demand for stomach tubes.

3. Development of Smart Stomach Tubes

The integration of sensor technology to monitor pH levels, feeding flow rates, and tube positioning is an emerging trend. These smart tubes can improve patient safety and reduce complications, creating opportunities for manufacturers.

Market by System Type Insights

Based on the system type, the market is segmented into:

Nasogastric Tubes (NG Tubes) – Expected to hold the largest market share due to their wide use in short-term feeding.

Gastrostomy Tubes (G-Tubes) – Expected to grow significantly, particularly among patients requiring long-term enteral feeding.

Jejunostomy Tubes (J-Tubes) – Preferred for patients with impaired gastric emptying, contributing to moderate market growth.

The Gastrostomy Tube segment is expected to witness the highest growth due to its increasing adoption in chronic care settings.

Market by End-Use Insights

Based on the end-use, the market is divided into:

Hospitals & Clinics – The largest segment, driven by increasing hospital admissions and advanced enteral nutrition management.

Homecare Settings – Witnessing rapid growth due to a rising preference for home-based care among elderly patients.

Ambulatory Surgical Centers (ASCs) – Experiencing steady growth with the increasing number of outpatient procedures requiring enteral feeding.

The Homecare segment is expected to exhibit the fastest growth, as more patients prefer enteral feeding in a home environment, reducing hospital stays and associated costs.

Market by Regional Insights

North America – Dominated the market in 2023, owing to advanced healthcare infrastructure, rising elderly population, and strong reimbursement policies.

Europe – Witnessing steady growth, supported by an increasing prevalence of gastrointestinal disorders and well-established homecare services.

Asia-Pacific – Expected to experience the highest growth rate due to rising healthcare investments, expanding medical facilities, and an aging population in countries like Japan, China, and India.

Latin America & Middle East & Africa – These regions are experiencing moderate growth due to improving healthcare awareness and increased access to medical devices.

Competitive Scenario

Major players in the Global Stomach Tube Market include:

Medtronic Plc

Boston Scientific Corporation

Becton, Dickinson and Company

Cardinal Health Inc.

B. Braun Melsungen AG

Fresenius Kabi AG

Cook Medical Inc.

Avanos Medical Inc.

Moog Inc.

Nestlé Health Science

Key players are focusing on product innovation, strategic partnerships, and geographic expansion to strengthen their market position.

In 2023, Medtronic launched an advanced anti-clogging gastrostomy tube, reducing maintenance issues and improving patient comfort.

In 2024, Becton Dickinson announced a new range of antimicrobial-coated stomach tubes aimed at reducing infection rates.

In 2025, Fresenius Kabi expanded its home enteral nutrition division, catering to the growing demand for home-based care.

Scope of Work – Global Stomach Tube Market

Report Metric Details

Market Size (2023) USD X.X billion

Projected Market Size (2031) USD X.X billion

CAGR (2023-2031) X.X%

Key Segments by System Type Nasogastric Tubes (NG Tubes), Gastrostomy Tubes (G-Tubes), Jejunostomy Tubes (J-Tubes)

Key Segments by End-Use Hospitals & Clinics, Homecare Settings, Ambulatory Surgical Centers (ASCs)

Leading Region North America

Key Players Medtronic Plc, Boston Scientific Corporation, Becton Dickinson, Cardinal Health, B. Braun Melsungen AG, Fresenius Kabi AG, Cook Medical, Avanos Medical, Moog Inc., Nestlé Health Science

Key Market Developments

2023 – Medtronic introduced a new gastrostomy tube with a clog-resistant feature, enhancing usability for long-term care patients.

2024 – Becton Dickinson launched a line of antimicrobial-coated stomach tubes, reducing the risk of infections in hospitalized patients.

2025 – Fresenius Kabi expanded its enteral nutrition services, providing enhanced support for homecare patients requiring stomach tube feeding.

FAQs

1. What is the current market size of the Global Stomach Tube Market?

The market was valued at USD X.X billion in 2023 and is projected to grow significantly by 2031.

2. What is the major growth driver of the Global Stomach Tube Market?

The rising prevalence of gastrointestinal disorders and increasing demand for enteral feeding in aging populations are key drivers.

3. Which region holds the largest market share in the stomach tube market?

North America dominated the market in 2023, driven by advanced healthcare infrastructure and growing awareness of enteral nutrition.

4. Which segment accounted for the largest market share in the stomach tube market?

The Gastrostomy Tube (G-Tube) segment held the largest market share due to its widespread use in long-term care settings.

5. Who are the key players in the stomach tube market?

Key players include Medtronic, Boston Scientific, Becton Dickinson, Cardinal Health, B. Braun Melsungen AG, and Fresenius Kabi.